| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 03/05/2008 | CN101137375A 抗炎化合物 Anti-inflammatory compounds |
| 03/05/2008 | CN101137374A Combination of a steroid sulfatase inhibitor and an ascomycin |
| 03/05/2008 | CN101137366A Compounds for treating autoimmune and demyelinating diseases |
| 03/05/2008 | CN101134088A Essential oil for recuperating human body and reliving aching pain and uses thereof |
| 03/05/2008 | CN101134068A Externally used drug for treating arthralgia and soft tissue injury and method for preparing the same |
| 03/05/2008 | CN101134062A Specific analgesic liniment |
| 03/05/2008 | CN101134042A Notoginsenoside pharmaceutical composition and method for preparing the same and use thereof |
| 03/05/2008 | CN101134035A Application of sophocarpine in the preparing of medicament for treating inflammation caused by influenza B virus |
| 03/05/2008 | CN101133872A Wilding synthesized three-rice lotus seed food granules and orange juice beverage and method for processing the same |
| 03/05/2008 | CN101133770A Fire-removing antiphlogistic tea |
| 03/05/2008 | CN100372849C Pyrrolo pyrimidine compounds as inhibitor of cysteine protease |
| 03/05/2008 | CN100372843C 2,5-disubstituted-1,3-dioxygen cycle compound, their synthesis and application as PKC inhibiter |
| 03/05/2008 | CN100372836C Immunotherapeutic imides/amides |
| 03/05/2008 | CN100372831C Sulfonic acids, their derivatives and pharmaceutical compositions containing them |
| 03/05/2008 | CN100372539C Pharmaceutical composition for use for the treatment of malignancies comprising in combination a bisphosphonates, a cox-2 inhibitor and a taxol |
| 03/05/2008 | CN100372532C Imidazolin-2-ylaminophenyl amides as IP antagonists. |
| 03/04/2008 | US7339038 Heparanase specific molecular probes and their use in research and medical applications |
| 03/04/2008 | US7339023 Angiogenesis inhibitors, antitumor agents |
| 03/04/2008 | US7338966 Substituted oxindole derivatives as tyrosine kinase inhibitors |
| 03/04/2008 | US7338959 N2-isopropyl-N5,1-dimethyl-N5-[2-({4-[(methylsulfonyl)methyl]phenyl}amino)pyrimidin-4-yl]-1H-benzimidazole-2,5-diamine; vascular endothelial growth factor (VEGF) receptor-2 and tyrosine kinase containing Ig and EGF homology domains (TIE) -2 inhibitor; antiproliferation and antihypoxic agent |
| 03/04/2008 | US7338659 Reducing immunogenicities of immunoglobulins by framework-patching |
| 03/04/2008 | US7338658 Chimeric antibody specific to human CD4 which comprises the variable heavy and light chain sequences of an Old World monkey monoclonal antibody produced against human CD4 and human constant heavy and light domain sequences |
| 03/04/2008 | US7338653 Amino-terminally truncated MCP-2 as chemokine antagonists |
| 03/04/2008 | CA2329210C Process for preparation of enantiomerically pure n-methyl-n-[(1s)-1-phenyl-2((3s)-3-hydroxypyrrolidin-1-yl) ethyl]-2,2-diphenylacetamide |
| 02/28/2008 | WO2008024981A1 Piperazine-substituted benzothiophenes for treatment of mental disorders |
| 02/28/2008 | WO2008024725A1 Aza-benzofuranyl compounds and methods of use |
| 02/28/2008 | WO2008024724A1 Aza-benzothiophenyl compounds and methods of use |
| 02/28/2008 | WO2008024433A2 Haloalkyl-substituted pyrimidinone derivatives |
| 02/28/2008 | WO2008023818A1 Fiber and method for production of fiber |
| 02/28/2008 | WO2008023336A2 Matrix metalloproteinase inhibitors |
| 02/28/2008 | WO2008023066A1 Imidazole compounds having an antiinflammatory effect |
| 02/28/2008 | WO2008011485A3 Methods for treating chronic pain |
| 02/28/2008 | WO2008006589A3 Compositions comprising rosehip and other active agents for the treatment of inflammatory disorders |
| 02/28/2008 | WO2008000744A3 2-0'-methyladen0sine derivatives and their use as agonists or antagonists of an adenosine receptor |
| 02/28/2008 | WO2007054904A3 Macrolides as anti-inflammatory agents |
| 02/28/2008 | WO2007016095A3 Cyclooxygenase-2 selective inhibitor compounds comprising nitric oxide enhancing groups, compositions and methods of use |
| 02/28/2008 | US20080051415 Novel piperazines, pharmaceutical compositions and methods of use thereof |
| 02/28/2008 | US20080051399 Hydroxylated and methoxylated pyrimidyl cyclopentanes as akt protein kinase inhibitors |
| 02/28/2008 | US20080051397 with polyglycolized glyceride (macrogol glyceride); Gelucires"; multiple sclerosis, asthma, scleroderma, endometriosis; 1,3-benzothiazol-2(3H)-ylidene{2-[(1,4-dimethylpiperazin-2-yl)methoxy]pyrimidin-4-yl}acetonitrile; adding to melt as powder under stirring resulting in homogeneous molten dispersion |
| 02/28/2008 | US20080051389 mimetics of the Smac peptide, used for the treatment of cancer and autoimmune disorders |
| 02/28/2008 | US20080051382 Crystalline Forms of 3-Beta-Amino 17-Methylene Androstane-6-Alpha 7-Beta-Diol Hydrochloride |
| 02/28/2008 | US20080051366 Aminosugar, glycosaminoglycan, and s-adenoslymethionine composition for the treatment and repair of connective tissue |
| 02/28/2008 | US20080051365 Treatment of Inflammation |
| 02/28/2008 | US20080051364 Therapeutic Treatment of Accelerated Bone Resorption |
| 02/28/2008 | US20080051359 Antisense oligonucleotide modulation of stat3 expression |
| 02/28/2008 | US20080051356 Truncated 24kDa basic fibroblast growth factor |
| 02/28/2008 | US20080051349 Peptide antagonists of zonulin and methods for use of the same |
| 02/28/2008 | US20080051338 98 Human Secreted Proteins |
| 02/28/2008 | US20080050458 Lupin Total Extract Consisting of a Lupin Sugar Extract and a Lupin Peptide Extract, Method for The Production and Use Thereof |
| 02/28/2008 | US20080050452 Metal-containing formulations and methods of use |
| 02/28/2008 | US20080050431 Sustained release formulations of oxymorphone |
| 02/28/2008 | US20080050427 Analgesic combination of tramadol and meloxicam |
| 02/28/2008 | US20080050384 Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors |
| 02/28/2008 | US20080050371 Comprises immunoglobulin for treating and preventing inflammation, thrombocytopenia and/or autoimmune hemolytic anemia |
| 02/28/2008 | US20080050368 Humanized immunoglobulin reactive with B7 molecules and methods of treatment therewith |
| 02/28/2008 | US20080050317 Oleaginous pharmaceutical and cosmetic foam |
| 02/28/2008 | US20080050315 Diagnostics and Therapeutics for Diseases Associated with Protein Kinase, Cgmp-Dependent, Type I (Prkg1) |
| 02/28/2008 | US20080050314 Diagnostics and Therapeutics for Diseases Associated With Glycogen Synthase Kinase 3 Beta (Gsk3b) |
| 02/28/2008 | DE602004007105T2 Zusammensetzung zur behandlung von gastrointestinalen störungen Composition for the treatment of gastrointestinal disorders |
| 02/28/2008 | DE19955576B4 Transferverbindungen, ihre Herstellung und ihre Verwendung Transfer compounds, their preparation and their use |
| 02/28/2008 | CA2661299A1 Matrix metalloproteinase inhibitors |
| 02/28/2008 | CA2660963A1 Aza-benzothiophenyl compounds and methods of use |
| 02/28/2008 | CA2660546A1 Aza-benzofuranyl compounds and methods of use |
| 02/28/2008 | CA2648521A1 1.alpha.-hydroxy-2-(3'-hydroxypropylidene)-19-n0r-vitamin d compounds with a 1,1-dimethylpropyl side chain |
| 02/27/2008 | EP1892299A2 Sense mRNA therapy |
| 02/27/2008 | EP1892297A2 Identification and molecular characterisation of proteins, expressed in the tick salivary glands |
| 02/27/2008 | EP1892251A2 B7-related nucleic acids and polypeptides and their uses for immunomodulation |
| 02/27/2008 | EP1892239A1 Inhibitors of cytosolic phospholipase A2 |
| 02/27/2008 | EP1892238A1 1, 2-di(cyclic group)substituted benzene derivative |
| 02/27/2008 | EP1891948A1 Treatment of neurological and neuropsychological disorders |
| 02/27/2008 | EP1891112A1 Methods of using pnkp30, a member of the b7 family, to modulate the immune system |
| 02/27/2008 | EP1891110A2 STABLE AND SOLUBLE ANTIBODIES INHIBITING TNF-alpha |
| 02/27/2008 | EP1891075A1 Tricyclic spiro derivatives as crth2 modulators |
| 02/27/2008 | EP1891066A2 Compounds and compositions as protein kinase inhibitors |
| 02/27/2008 | EP1891039A1 Quinoline derivatives useful as modulators of ion channels |
| 02/27/2008 | EP1891029A1 Organic compounds for the treatment of imflammatory or alleric conditions |
| 02/27/2008 | EP1891008A1 Oxindoles as kinase inhibitors |
| 02/27/2008 | EP1890993A2 Benzoic acid derivatives that are modulators or antagonists of glyr |
| 02/27/2008 | EP1890729A2 Use of carotenoids and/or carotenoid derivatives/analogs for reduction/inhibition of certain negative effects of cox inhibitors |
| 02/27/2008 | EP1890546A1 A composition to enhance the bioavailability of curcumin |
| 02/27/2008 | EP1509251B1 Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 02/27/2008 | EP1506958B1 Process for producing shogaol and intermediates for the synthesis thereof |
| 02/27/2008 | EP1506192B1 Substituted pyrroline kinase inhibitors |
| 02/27/2008 | EP1496873B1 Chewable soft capsule |
| 02/27/2008 | EP1483266B1 Spiro compounds with npy antagonistic activity |
| 02/27/2008 | EP1471143B1 Method and kit of judging the onset of rheumatoid arthritis |
| 02/27/2008 | EP1446115B1 Cyanoalkylamino derivatives as protease inhibitors |
| 02/27/2008 | EP1341811B1 Orally ingestible preparation of mistletoe lectins and method |
| 02/27/2008 | EP1318994B1 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists |
| 02/27/2008 | EP1248612B1 Novel compounds and compositions as protease inhibitors |
| 02/27/2008 | EP1150959B1 Solid-state form of celecoxib having enhanced bioavailability |
| 02/27/2008 | EP1149105B1 4,5-pyrazinoxindoles as protein kinase inhibitors |
| 02/27/2008 | EP1141278B1 Therapeutic pde4d phosphodiesterase inhibitors |
| 02/27/2008 | EP0739350B1 Ligand that binds fas antigen |
| 02/27/2008 | CN201026309Y Improved structure of agentia plaster |
| 02/27/2008 | CN101133037A 6-membered heterocyclic compound and use thereof |
| 02/27/2008 | CN101132832A Treatment for inflammation |
| 02/27/2008 | CN101132806A Method of reducing oral tissue inflammation using magnolia extract |
| 02/27/2008 | CN101130091A DNA vaccine for treating atrophic arthritis and uses of the same |
| 02/27/2008 | CN101130052A Traditional Chinese medicine for treating post partum paralysis |